Skip to main content

Advertisement

Advertisement

Business

Pfizer, BioNTech can raise capacity to 3 billion COVID-19 vaccine doses next year: Report

Pfizer, BioNTech can raise capacity to 3 billion COVID-19 vaccine doses next year: Report

FILE PHOTO: Vials of Pfizer's coronavirus disease (COVID-19) vaccine are seen at a pop-up community vaccination center at the Gateway World Christian Center in Valley Stream, New York, U.S., February 23, 2021. REUTERS/Brendan McDermid/File Photo

BioNTech SE could have capacity to make 3 billion doses of the COVID-19 vaccine it developed with partner Pfizer next year, Bloomberg News reported on Tuesday (Mar 9), citing an interview with the German company's chief executive officer.

While BioNTech could increase manufacturing capacity in principle, it depends on demand and factors such as requirement of additional boost to vaccinations, CEO Ugur Sahin told Bloomberg News. 

Pfizer last month said it aims to make at least 2 billion doses of its COVID-19 vaccine in 2021.

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram

Source: Reuters

Advertisement

Also worth reading

Advertisement